Dr. Hamid R. Mirshahidi
Claim this profileLoma Linda University Medical Center
Area of expertise
Lung Cancer
Hamid R. Mirshahidi has run 8 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Hamid R. Mirshahidi has run 8 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Loma Linda University Medical Center
Clinical Trials Hamid R. Mirshahidi is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting
1 award
Phase 2
11 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
More about Hamid R. Mirshahidi
Clinical Trial Related
6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Hamid R. Mirshahidi has experience with
- Pembrolizumab
- Atezolizumab
- Carboplatin
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
- Ramucirumab
Breakdown of trials Hamid R. Mirshahidi has run
Lung Cancer
Non-Small Cell Lung Cancer
Glioblastoma
Kidney Cancer
Thyroid Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hamid R. Mirshahidi specialize in?
Hamid R. Mirshahidi focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Hamid R. Mirshahidi currently recruiting for clinical trials?
Yes, Hamid R. Mirshahidi is currently recruiting for 3 clinical trials in Loma Linda California. If you're interested in participating, you should apply.
Are there any treatments that Hamid R. Mirshahidi has studied deeply?
Yes, Hamid R. Mirshahidi has studied treatments such as Pembrolizumab, Atezolizumab, Carboplatin.
What is the best way to schedule an appointment with Hamid R. Mirshahidi?
Apply for one of the trials that Hamid R. Mirshahidi is conducting.
What is the office address of Hamid R. Mirshahidi?
The office of Hamid R. Mirshahidi is located at: Loma Linda University Medical Center, Loma Linda, California 92354 United States. This is the address for their practice at the Loma Linda University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.